Rallybio Corp (RLYB) — Strategic Asset Allocation Index
Rallybio Corp (RLYB) has a Strategic Asset Allocation Index of 1.4% as of June 2025. Strategic assets (PP&E of $- plus long-term investments of $626.00K) total $626.00K, measured against net assets of $45.96 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Rallybio Corp net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Rallybio Corp Strategic Asset Allocation Index (2019–2024)
This chart shows how Rallybio Corp's Strategic Asset Allocation Index has evolved across 6 annual periods from 2019 to 2024. As of June 2025, the index stands at 1.4%, representing strategic assets of $626.00K against net assets of $45.96 Million USD. For live market cap and overall valuation, see RLYB market cap overview.
Annual Strategic Asset Allocation Index for Rallybio Corp (2019–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Rallybio Corp from 2019 to 2024, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See what is Rallybio Corp's book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.0% | $0.00 | $- | $0.00 | $61.65 Million | ▼ -0.2 pp |
| 2023 | 0.2% | $239.00K | $- | $239.00K | $106.18 Million | ▼ 0.0 pp |
| 2022 | 0.2% | $415.00K | $385.00K | $30.00K | $169.32 Million | ▼ -0.5 pp |
| 2021 | 0.7% | $1.32 Million | $511.00K | $805.00K | $175.60 Million | ▲ +0.3 pp |
| 2020 | 0.4% | $597.00K | $287.00K | $310.00K | $136.00 Million | ▼ -3.6 pp |
| 2019 | 4.1% | $687.00K | $199.00K | $488.00K | $16.86 Million | — |